Published in Blood Weekly, July 17th, 2003
"To establish the incidence of CMV viremia after allogeneic blood stem cell transplantation," researchers in the United States performed a study involving "51 consecutive allogeneic peripheral blood stem cell (PBSC) transplant recipients."
"A total of 12 recipients were at moderate risk for CMV disease," while 39 patients "were at high risk," noted A. Verma and coauthors at the University of Chicago.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.